ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025
Erratum: Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.
Yutaka Yamamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.